Researchers Create Accurate, Non-Invasive Test for Major Liver Diseases
This liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MorePosted by Andy Lundin | Jul 14, 2022 | Diabetes & Metabolic Diseases |
This liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MorePosted by Chris Wolski | Jul 12, 2022 | Emerging & Zoonotic Diseases |
Recent research inquires into the evolutionary dynamic of the global risk of yellow fever transmission to humans.
Read MorePosted by Chris Wolski | Jul 12, 2022 | Disease States |
Scientists announced a significant advance in the understanding of a very rare condition called alternating hemiplegia of childhood (AHC).
Read MorePosted by Chris Wolski | Jul 12, 2022 | Molecular Diagnostics |
A new study found that pharmacogenomic genetic testing can help providers avoid prescribing antidepressant medications.
Read MorePosted by Andy Lundin | Jul 11, 2022 | Company News |
Meridian Bioscience, a provider of diagnostic testing solutions and life science raw materials, entered into a definitive merger agreement.
Read More